Core Insights - Intelligent Bio Solutions Inc. has successfully collected new data that reinforces the security and performance of its Intelligent Fingerprinting Drug Screening System, which is crucial for its FDA 510(k) submission [2][5] - The company has engaged in constructive dialogue with the FDA and plans to submit findings along with new data in August [3][5] - The technology utilizes advanced quantification techniques to measure trace sweat volumes, confirming its ability to detect minute levels of sweat in a single fingerprint [4][5] Company Overview - Intelligent Bio Solutions Inc. is a medical technology company focused on delivering rapid, non-invasive testing solutions, particularly through its Intelligent Fingerprinting Drug Screening System [6] - The system screens for recent drug use, including opiates, cocaine, methamphetamine, and cannabis, and is designed for safety-critical industries [6] - The company currently supports over 450 accounts across 24 countries and is expanding its global reach through 18 distribution partners [5][6] Regulatory and Technical Developments - The company has completed rigorous cybersecurity testing to validate the resilience of its system, confirming its strength in secure and varied operating environments [3] - The R&D team has invested over 6,000 hours into testing, data aggregation, analysis, and technical reporting to enhance the quality of the FDA submission [5] - The technology is capable of measuring down to 0.0000001 grams, which is approximately 10 million times lighter than a U.S. one-dollar bill, showcasing its precision [4]

Company Overview - Intelligent Bio Solutions Inc. (INBS) is a medical technology company focused on delivering intelligent, rapid, non-invasive testing solutions [6] - The company aims to revolutionize portable testing through its Intelligent Fingerprinting Drug Screening System, which analyzes fingerprint sweat for drug use [6] Partnership and Product Expansion - INBS announced a global distribution agreement with SMARTOX® to introduce the SmarTest Patch drug detection product to international markets outside the U.S. and Canada [1][2] - The SmarTest Patch enhances INBS's product portfolio by providing continuous sweat-based drug detection over an extended period, targeting sectors such as justice and rehabilitation [2][3] Market Potential - The global drug testing market is projected to grow significantly, reaching approximately $18.6 billion by 2030, presenting new opportunities for INBS [2] - The partnership with SMARTOX supports INBS's international growth strategy and introduces an additional revenue stream aligned with its broader expansion goals [2] Regulatory Strategy - INBS is prioritizing securing FDA clearance for its fingerprint sweat-based drug testing technology for use beyond forensic settings as part of its U.S. expansion strategy [4] - The company is actively engaging with regulatory consultants and stakeholders to bring its innovative solution to market in the U.S. [4] Current Operations - INBS currently serves over 450 active accounts in 24 countries, providing non-invasive drug testing solutions across health, justice, and workplace sectors [3]

Core Insights - Intelligent Bio Solutions Inc. has introduced the SmarTest® Patch, a non-invasive drug testing solution that detects substances through sweat over a 7 to 10-day period [1][2] - The SmarTest Patch complements the existing Intelligent Fingerprinting Drug Testing Solution, enhancing the company's product portfolio in non-invasive testing technologies [1][2] Product Features - The SmarTest Patch is discreet, water-resistant, and tamper-evident, designed to continuously collect sweat for drug detection [2] - It can detect a wide range of substances, including cocaine, opiates, methamphetamines, marijuana, and fentanyl [2] - The differing detection windows of the SmarTest Patch and the Intelligent Fingerprinting Drug Screening System allow the company to meet varied customer requirements [2][3] Market Opportunities - The introduction of the SmarTest Patch opens new opportunities in markets requiring longer detection windows, particularly in justice and rehabilitation settings [3] - The product enhances the company's commercial edge by providing customers with more adaptable tools for both short and long-term detection needs [3] Company Background - Intelligent Bio Solutions Inc. focuses on delivering rapid, non-invasive testing solutions and aims to revolutionize portable testing through fingerprint sweat analysis [5] - The company targets various customer segments outside the U.S., including construction, manufacturing, transport, and drug treatment organizations [5] Partner Information - SMARTOX, the developer of the SmarTest Patch, is a U.S.-based provider of drug and alcohol testing products and services, committed to advanced technology and exceptional results [4] - SMARTOX is actively expanding its presence in forensic testing markets through investments and pilot programs [4]

Core Insights - Intelligent Bio Solutions Inc. (INBS) is set to present its Pharmacokinetic (PK) study data at the ADLM 2025 Clinical Lab Expo, showcasing the effectiveness of its Intelligent Fingerprinting Drug Screening System for non-invasive drug testing [2][4]. Group 1: Study Findings - The PK study demonstrated that fingerprint sweat can accurately reflect the rate and extent of codeine found in blood and saliva, indicating its reliability for drug detection [3]. - Statistical comparisons at a 95% confidence level confirmed that fingerprint sweat serves as a dependable sample matrix for drug screening [3]. Group 2: Event Participation - Daniel Brown, Head of Clinical Affairs at INBS, will represent the company at the ADLM event, engaging with attendees and presenting the study's methodology and findings [4]. - ADLM 2025 is a significant global exposition for laboratory medicine, featuring over 300 expert speakers and more than 250 educational sessions [5]. Group 3: Company Overview - INBS's Drug Screening System is designed for accurate and efficient testing across various sectors, including construction, transportation, and manufacturing, with over 450 accounts in 24 countries [7]. - The Intelligent Fingerprinting Drug Screening System aims to revolutionize portable testing through rapid sample collection and results, making it a valuable tool for safety-critical industries [8].

Core Insights - Intelligent Bio Solutions Inc. (INBS) is advancing drug screening technology through its partnership with Spjotgard, enhancing the adoption of its Intelligent Fingerprinting Drug Screening System in Scandinavia [1][6] - Spjotgard, established in 2021, has positioned INBS' technology as a leading solution in response to the demand for modern drug testing methods [2][7] - The fingerprint drug testing system is gaining traction due to its non-invasive nature, quick results, and suitability for various sectors including logistics, construction, and education [3][5][10] Company Overview - Intelligent Bio Solutions Inc. specializes in non-invasive drug testing solutions, with a focus on fingerprint sweat analysis for rapid results [10] - The company has over 450 accounts across 24 countries, indicating a strong market presence and ongoing evolution in drug screening technology [6] - INBS' Drug Screening System is designed to be hygienic and cost-effective, screening for commonly used drugs in workplace settings [10] Market Dynamics - There is a growing interest in fingerprint-based testing in Scandinavia, driven by the need for more hygienic and less invasive drug testing alternatives [3][5] - Spjotgard is expanding its market presence through collaborations with drug-detection service providers and is actively targeting Norway for future growth [4][5] - The Scandinavian region, particularly Sweden, is recognized for its progressive drug testing policies, setting a standard for neighboring countries [5]

Core Insights - Intelligent Bio Solutions Inc. (INBS) has partnered with Managed Waste Service (MWS) to implement its Intelligent Fingerprinting Drug Screening System across MWS's operations in New South Wales, Australia [1][2] - This marks MWS's first initiative for in-house drug testing at over 20 sites, allowing for pre-employment, random, and for-cause testing on-site [2][3] - The Intelligent Fingerprinting Drug Screening System provides results in under ten minutes through fingerprint sweat analysis, enhancing safety and compliance in the workplace [3][4] Company Overview - Intelligent Bio Solutions Inc. specializes in rapid, non-invasive testing solutions, with a focus on drug screening through fingerprint analysis [1][6] - The company aims to revolutionize portable testing, offering a hygienic and cost-effective method to screen for drugs commonly found in the workplace [6] - INBS's technology is currently utilized by over 450 organizations across 24 countries, indicating a growing acceptance of sweat-based drug testing in various sectors [4][6] Industry Context - The implementation of INBS's drug screening system reflects a trend in safety-critical industries seeking innovative and scalable solutions for managing safety and risk [4] - The partnership with MWS highlights the increasing recognition of fingerprint drug testing as an effective and dignified option for workplace safety [4] - MWS is committed to landfill reduction and advancing a circular economy, providing waste management solutions that align with sustainability goals [5]

Core Insights - Intelligent Bio Solutions (INBS) has expanded its presence in the U.S. forensic market through a partnership with SMARTOX, enhancing its drug detection capabilities using fingerprint sweat technology [1][2][8] - The collaboration is expected to improve operational efficiency and hygiene in drug testing, while also positioning INBS for broader market expansion, including workplace drug testing [2][4][9] - INBS's stock has seen a year-to-date increase of 36.4%, significantly outperforming the industry average of 2.6% [3] Company Developments - The partnership with SMARTOX allows INBS to leverage a strong distribution network, facilitating the deployment of over 50 drug screening devices across various U.S. institutions, resulting in over 7,000 tests conducted [8] - INBS is pursuing FDA 510(k) clearance for its opiate test system, which will enable entry into high-value markets such as workplace safety and clinical diagnostics [9] - The company currently has a market capitalization of $13.2 million and anticipates an 80.4% growth in earnings for 2025 [5] Industry Outlook - The global drug screening market is projected to grow from $9.1 billion in 2024 to $19.5 billion by 2029, with a compound annual growth rate (CAGR) of 16.6%, driven by increased drug consumption and stricter testing regulations [10]

Core Insights - Intelligent Bio Solutions Inc. (INBS) is expanding its presence in the U.S. Forensic Use Only Market through a partnership with SMARTOX, having deployed over 50 Intelligent Fingerprinting Drug Screening Readers and conducted over 7,000 screening tests, including more than 1,500 in 2024 [1][2][3] Company Overview - INBS specializes in intelligent, rapid, non-invasive testing solutions, particularly in drug screening technology that reduces reliance on invasive methods [2][7] - SMARTOX, founded in 2012, provides drug and alcohol testing products and services across various sectors, including healthcare and criminal justice, and is committed to innovation and customer service [6] Market Demand and Technology - There is an accelerated demand for non-invasive, rapid testing in forensic settings, with INBS's technology credited for improving efficiency and user dignity while simplifying operations [2][5] - The Intelligent Fingerprinting Drug Screening System allows for hygienic, non-invasive drug screening in under ten minutes using fingerprint sweat, which is beneficial for safety-critical industries [4][7] Regulatory Efforts - INBS is actively pursuing FDA clearance for its opiate test system for codeine, aiming for broader market expansion in 2025, including workplace drug testing [3][4]

Core Insights - Intelligent Bio Solutions Inc. (INBS) will participate in the RISE25 conference, focusing on addiction, mental health, and justice innovation, which attracts over 7,000 attendees annually [1][3] - The company aims to showcase its Intelligent Fingerprinting Drug Testing Solution, which is currently utilized in the U.S. for forensic purposes through its partnership with SMARTOX [1][2] Company Overview - INBS is a medical technology company specializing in rapid, non-invasive testing solutions, with over 450 active accounts across 24 countries [1][4] - The Intelligent Fingerprinting Drug Screening System detects recent drug use through fingerprint sweat, providing results in under ten minutes, making it suitable for treatment courts and probation programs [2][6] Market Context - RISE25 serves as a national platform for professionals in public health and justice, focusing on evidence-based approaches for individuals affected by substance use and mental health issues [3][4] - The U.S. market for forensic use of drug testing presents significant expansion opportunities for INBS, which believes its technology can deliver substantial benefits in this sector [4] Strategic Partnerships - INBS collaborates with SMARTOX, a U.S.-based provider of drug and alcohol testing products, to enhance its market presence and support innovative solutions in various sectors [5][6] - The partnership aims to address the growing demand for reliable on-site drug testing solutions across workplaces, treatment facilities, and the justice system [1][4]

Core Insights - Intelligent Bio Solutions Inc. successfully completed a high-volume workforce drug test for Barcaldine Regional Council in Queensland, Australia, demonstrating the speed and efficiency of its Intelligent Fingerprinting Drug Screening System [1][2][5] - The testing process was completed in less than 90 minutes for over 160 employees, ensuring minimal disruption to business operations [2][4] - The company’s system allows for on-site testing, which is particularly beneficial for remote locations, and has opened new market opportunities for the company [4][5] Company Overview - Intelligent Bio Solutions Inc. is a medical technology company focused on delivering rapid, non-invasive testing solutions, particularly through its Intelligent Fingerprinting Drug Screening System [6][7] - The system screens for recent drug use via fingerprint sweat analysis, providing results in under ten minutes, making it a hygienic and cost-effective solution for employers in safety-critical industries [6][7] - The company has over 450 accounts across 24 countries, serving various industries including construction, manufacturing, transport, and logistics [5][6] Market Expansion - The successful deployment of the testing system in Queensland supports the company's growth efforts in the Asia-Pacific region, with expectations for further expansion as demand for efficient workplace drug testing rises [5] - Following the initial test, the Council personnel were trained to conduct random testing in-house, indicating a shift towards a fully managed, on-location service model [4][5] - The company aims to revolutionize portable testing and expand its applications beyond current markets, leveraging its innovative technology [6][7]